Is a complete CANF research report available?

No complete published report is available for Can-Fite BioPharma Ltd. (CANF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Can-Fite BioPharma Ltd. (CANF)

NYSEAMERICAN: CANF · USD

$1.64

+0.02 (+1.2%)· Recorded snapshot

Market cap	5.2M
Revenue (ttm)	405K
Net income (ttm)	-9.6M
EPS (ttm)	-$6.14
Shares out	4.3M
Volume	13,283
Beta	-0.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 405K
Net income (ttm): -9.6M
EPS (ttm): -$6.14
Market cap: 5.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Metric	Value
Amount currency	USD
CIK code	0001536196
Company name	Can-Fite BioPharma Ltd.
Country	Israel
Country code	US
CUSIP number	13471N409
Earnings date	2026-09-08
Earnings time	bmo
Employees	5
Employees change	-3
Employees growth	-37.5%
Enterprise value	$-1.3M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1994
Industry	Biotechnology
Is primary listing	No
Is SPAC	No
ISIN number	US13471N4097
Last 10-K release date	2026-03-26
Last earnings date	2026-09-08
Last refreshed	2026-11-04
Last stock split date	2026-01-05
Last stock split type	Reverse
Market cap	$5.2M
Market cap category	Nano-Cap
Next earnings date	2027-03-25
Options	No
Price	$1.64
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-04
Symbol	CANF
Website	https://www.canfite.com

Metric

Value

Amount currency

USD

CIK code

0001536196

Company name

Can-Fite BioPharma Ltd.

Country

Israel

Country code

CUSIP number

13471N409

Earnings date

2026-09-08

Earnings time

bmo

Employees

Employees change

-3

Employees growth

-37.5%

Enterprise value

$-1.3M

Exchange

NYSEAMERICAN

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1994

Industry

Biotechnology

Is primary listing

Is SPAC

ISIN number

US13471N4097

Last 10-K release date

2026-03-26

Last earnings date

2026-09-08

Last refreshed

2026-11-04

Last stock split date

2026-01-05

Last stock split type

Reverse

Market cap

$5.2M

Market cap category

Nano-Cap

Next earnings date

2027-03-25

Options

Price

$1.64

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-11-04

Symbol

CANF

Website

https://www.canfite.com

Metric	Value
Earnings yield	-374.51%
FCF / EV yield	678.15%
FCF yield	-183.71%
Forward P/S	25.64x
P/B ratio	1.07x
P/S ratio	12.79x
Price / tangible book value	1.07x
Sector forward P/E	24x
Sector P/E	49.18x

Metric

Value

Earnings yield

-374.51%

FCF / EV yield

678.15%

FCF yield

-183.71%

Forward P/S

25.64x

P/B ratio

1.07x

P/S ratio

12.79x

Price / tangible book value

1.07x

Sector forward P/E

24x

Sector P/E

49.18x

Metric	Value
Gross margin	100%
Operating margin	-2,402.96%
Pretax margin	-2,358.77%
Profit per employee	$-1.9M
Revenue per employee	$81,000
ROA	-77.12%
ROA (5Y)	-53.94%
ROCE	-166.93%
ROE	-211.37%
ROE (5Y)	-137.38%
ROIC	-132.55%
SBC / revenue	44.69%

Metric

Value

Gross margin

100%

Operating margin

-2,402.96%

Pretax margin

-2,358.77%

Profit per employee

$-1.9M

Revenue per employee

$81,000

ROA

-77.12%

ROA (5Y)

-53.94%

ROCE

-166.93%

ROE

-211.37%

ROE (5Y)

-137.38%

ROIC

-132.55%

SBC / revenue

44.69%

Metric	Value
EPS growth years	7
Gross profit growth	-27.68%
Gross profit growth (Q)	-36.08%
Gross profit growth 3Y	-20.07%
Gross profit growth 5Y	-11.81%
Net income growth years	0
Revenue growth	-27.68%
Revenue growth (QoQ)	-0.49%
Revenue growth 10Y	6.92%
Revenue growth 3Y	-20.07%
Revenue growth 5Y	-11.81%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

-27.68%

Gross profit growth (Q)

-36.08%

Gross profit growth 3Y

-20.07%

Gross profit growth 5Y

-11.81%

Net income growth years

Revenue growth

-27.68%

Revenue growth (QoQ)

-0.49%

Revenue growth 10Y

6.92%

Revenue growth 3Y

-20.07%

Revenue growth 5Y

-11.81%

Revenue growth years

Metric	Value
Capital expenditures	$-2,000
Depreciation and amortization	$2,000
EBIT	$-9.7M
EBITDA	$-9.7M
EPS	$-6.14
FCF per share	$-2.22
Financing cash flow	$10M
Free cash flow	$-9.5M
Free cash flow minus SBC	$-9.7M
Gross profit	$405,000
Investing cash flow	$-4M
Net cash flow	$-3.5M
Net income	$-9.6M
Operating cash flow minus SBC	$-9.7M
Operating income	$-9.7M
Revenue	$405,000
Stock-based compensation	$181,000

Metric

Value

Capital expenditures

$-2,000

Depreciation and amortization

$2,000

EBIT

$-9.7M

EBITDA

$-9.7M

EPS

$-6.14

FCF per share

$-2.22

Financing cash flow

$10M

Free cash flow

$-9.5M

Free cash flow minus SBC

$-9.7M

Gross profit

$405,000

Investing cash flow

$-4M

Net cash flow

$-3.5M

Net income

$-9.6M

Operating cash flow minus SBC

$-9.7M

Operating income

$-9.7M

Revenue

$405,000

Stock-based compensation

$181,000

Metric	Value
Altman Z-Score	-32.41
Book value per share	$1.13
Debt / equity	0.01
Long-term assets	$52,000
Long-term liabilities	$975,000
Net cash (debt)	$7M
Net cash / market cap	135.06%
Net cash growth	49.73%
Net debt / equity	-1.44
Piotroski F-Score	2
Property, plant and equipment	$52,000
Shareholders' equity	$4.9M
Tangible book value	$4.9M
Tangible book value per share	$1.13
Total assets	$8.1M
Total cash	$7M
Total debt	$49,000
Total liabilities	$3.2M
WACC	4.1%

Metric

Value

Altman Z-Score

-32.41

Book value per share

$1.13

Debt / equity

0.01

Long-term assets

$52,000

Long-term liabilities

$975,000

Net cash (debt)

$7M

Net cash / market cap

135.06%

Net cash growth

49.73%

Net debt / equity

-1.44

Piotroski F-Score

Property, plant and equipment

$52,000

Shareholders' equity

$4.9M

Tangible book value

$4.9M

Tangible book value per share

$1.13

Total assets

$8.1M

Total cash

$7M

Total debt

$49,000

Total liabilities

$3.2M

WACC

4.1%

Metric	Value
Asset turnover	0.05
Current assets	$8M
Current liabilities	$2.2M
Current ratio	3.6
Net working capital	$-1.2M
Quick ratio	3.17
Working capital	$5.8M
Working capital turnover	0.08

Metric

Value

Asset turnover

0.05

Current assets

$8M

Current liabilities

$2.2M

Current ratio

3.6

Net working capital

$-1.2M

Quick ratio

3.17

Working capital

$5.8M

Working capital turnover

0.08

Metric	Value
Buyback yield / dilution	-196.15%
Dividend yield	0%
Shareholder yield	-196.15%

Metric

Value

Buyback yield / dilution

-196.15%

Dividend yield

Shareholder yield

-196.15%

Metric	Value
10Y price change	-99.98%
10Y return CAGR	-56.48%
10Y total return	-99.98%
150-day SMA	$2.87
1D price change	1.23%
1M price change	-23.46%
1M total return	-23.46%
1W price change	1.21%
1W total return	1.21%
1Y price change	-79.72%
1Y return CAGR	-79.75%
1Y total return	-79.72%
20-day SMA	$1.79
200-day SMA	$3.17
3M price change	-47.32%
3M total return	-47.32%
3Y price change	-96.16%
3Y return CAGR	-66.26%
3Y total return	-96.16%
50-day SMA	$2.16
50-day SMA vs 200-day SMA	50under200
52-week high	$12.30
52-week high date	2025-11-18
52-week low	$1.50
52-week low date	2026-11-04
5Y price change	-99.44%
5Y return CAGR	-64.55%
5Y total return	-99.44%
6M price change	-43%
6M total return	-43%
All-time high	$28,380.00
All-time high date	2013-12-23
All-time low	$1.50
All-time low date	2026-11-04
Average true range (ATR)	$0.10
Average volume	67.8K
Beta (5Y)	-0.02
Change from 52-week high	-86.67%
Change from 52-week low	9.33%
Change from all-time high	-99.99%
Change from all-time low	11.33%
Change from open	9.33%
Day's gap	-7.41%
Dollar volume	$21,784
High price	$1.68
Low price	$1.50
Monthly RSI	26.1
Open price	$1.50
Position in 52-week range	80%
Premarket change	-3.7%
Premarket close	$1.62
Premarket price	$1.56
Premarket volume	875
Previous close	$1.62
Price vs 150-day SMA	-41.77%
Price vs 20-day SMA	-6.81%
Price vs 200-day SMA	-47.37%
Price vs 50-day SMA	-22.61%
Relative volume	0.2
RSI	30.62
Sharpe ratio	-1.08
Sharpe ratio (3Y)	-0.89
Sharpe ratio (5Y)	-0.86
Sortino ratio	-1.57
Sortino ratio (3Y)	-1.21
Sortino ratio (5Y)	-1.22
Volume	13.3K
Weekly RSI	26.42
YTD price change	-58.25%
YTD total return	-58.25%

Metric

Value

10Y price change

-99.98%

10Y return CAGR

-56.48%

10Y total return

-99.98%

150-day SMA

$2.87

1D price change

1.23%

1M price change

-23.46%

1M total return

-23.46%

1W price change

1.21%

1W total return

1.21%

1Y price change

-79.72%

1Y return CAGR

-79.75%

1Y total return

-79.72%

20-day SMA

$1.79

200-day SMA

$3.17

3M price change

-47.32%

3M total return

-47.32%

3Y price change

-96.16%

3Y return CAGR

-66.26%

3Y total return

-96.16%

50-day SMA

$2.16

50-day SMA vs 200-day SMA

50under200

52-week high

$12.30

52-week high date

2025-11-18

52-week low

$1.50

52-week low date

2026-11-04

5Y price change

-99.44%

5Y return CAGR

-64.55%

5Y total return

-99.44%

6M price change

-43%

6M total return

-43%

All-time high

$28,380.00

All-time high date

2013-12-23

All-time low

$1.50

All-time low date

2026-11-04

Average true range (ATR)

$0.10

Average volume

67.8K

Beta (5Y)

-0.02

Change from 52-week high

-86.67%

Change from 52-week low

9.33%

Change from all-time high

-99.99%

Change from all-time low

11.33%

Change from open

9.33%

Day's gap

-7.41%

Dollar volume

$21,784

High price

$1.68

Low price

$1.50

Monthly RSI

26.1

Open price

$1.50

Position in 52-week range

80%

Premarket change

-3.7%

Premarket close

$1.62

Premarket price

$1.56

Premarket volume

875

Previous close

$1.62

Price vs 150-day SMA

-41.77%

Price vs 20-day SMA

-6.81%

Price vs 200-day SMA

-47.37%

Price vs 50-day SMA

-22.61%

Relative volume

0.2

RSI

30.62

Sharpe ratio

-1.08

Sharpe ratio (3Y)

-0.89

Sharpe ratio (5Y)

-0.86

Sortino ratio

-1.57

Sortino ratio (3Y)

-1.21

Sortino ratio (5Y)

-1.22

Volume

13.3K

Weekly RSI

26.42

YTD price change

-58.25%

YTD total return

-58.25%

Metric	Value
Float	6.1M
Float percentage	141.49%
Shares change (QoQ)	72.2%
Shares change (YoY)	196.15%
Shares held by insiders	0%
Shares held by institutions	2.82%
Shares outstanding	4.3M
Short % of shares	1.12%
Short ratio	0.8 days

Metric

Value

Float

6.1M

Float percentage

141.49%

Shares change (QoQ)

72.2%

Shares change (YoY)

196.15%

Shares held by insiders

Shares held by institutions

2.82%

Shares outstanding

4.3M

Short % of shares

1.12%

Short ratio

0.8 days

Can-Fite BioPharma Ltd. (CANF)

Price

Financial snapshot

Fair-value bridge

Latest news · CANF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CANF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CANF

Frequently asked questions